Beauty Devices
China's New Regulations on RF Beauty Devices: Exporters Must Obtain Medical Device Certification Starting April 1, 2026
Beauty Industry Analyst
Publication Date:Mar 30, 2026
Views:
China's New Regulations on RF Beauty Devices: Exporters Must Obtain Medical Device Certification Starting April 1, 2026

China's New Regulations on RF Beauty Devices: Exporters Must Obtain Medical Device Certification Starting April 1, 2026

Introduction

Starting April 1, 2026, China's National Medical Products Administration (NMPA) will classify radiofrequency (RF) therapy devices and RF skin treatment devices as Class III medical devices, requiring manufacturers to obtain medical device registration certificates. This policy shift impacts domestic producers exporting to markets like the EU, Middle East, and Southeast Asia, where these products were previously registered as household appliances. The change mandates stricter quality control, clinical evaluations, and labeling compliance. Industry players—particularly exporters, OEMs, and overseas importers—must adapt to avoid supply chain disruptions and regulatory penalties.

Event Overview

As confirmed by the NMPA, RF beauty devices will be reclassified under Class III medical device management from April 1, 2026. Manufacturers must secure registration certificates to continue production, sales, or exports. Products lacking certification will be banned from the Chinese market and face export restrictions. Notably, this affects devices previously labeled as household appliances, now subject to medical-grade standards, including clinical trials and factory inspections.

Impact on Sub-Industries

1. Export Manufacturers

Chinese OEMs supplying RF devices to international markets must overhaul production lines to meet medical device standards. From an industry perspective, this entails:

  • Upgrading quality management systems (e.g., ISO 13485 compliance).
  • Conducting clinical evaluations—a cost and time-intensive process.
  • Adjusting export declarations, as products can no longer be shipped under家电 (household appliance) HS codes.

2. Overseas Importers

EU and Middle Eastern buyers sourcing from China face:

  • Mandatory re-verification of suppliers' certifications.
  • Potential customs rejections for non-compliant shipments post-April 2026.
  • Liability risks if uncertified products trigger market recalls.

3. Supply Chain Service Providers

Logistics and certification agencies must prepare for:

  • Delays due to revised export documentation.
  • Increased demand for medical device testing and compliance consulting.

Key Actions for Stakeholders

1. Verify Supplier Compliance

Importers should audit Chinese manufacturers' registration progress. Current priorities include:

  • Requesting draft registration certificates or approval timelines.
  • Confirming factory upgrades to medical device GMP standards.

2. Redesign Procurement Timelines

With clinical evaluations potentially taking 12–18 months, buyers may need to:

  • Secure pre-certified inventory before April 2026.
  • Explore alternative suppliers with existing medical device licenses.

3. Monitor Regulatory Updates

NMPA may issue细化规则 (detailed rules) for transitional arrangements. Watching for:

  • Grace periods for inventory clearance.
  • Updates to RF device classification scope (e.g., power output thresholds).

Editorial Perspective

Analysis suggests this policy reflects China's alignment with global medical device trends, similar to the EU's MDR. However:

  • It’s a proactive signal rather than an immediate crisis—most exporters have a 2-year window to adapt.
  • The real bottleneck lies in clinical data collection, where smaller manufacturers may struggle.
  • Importers should treat this as a supply chain diversification prompt, not just a compliance checkbox.

Conclusion

China's RF device reclassification underscores tightening cross-border health product regulations. While the policy aims to standardize quality, its ripple effects will reshape export dynamics—particularly for beauty tech OEMs and their global partners. Stakeholders should approach this as a phased transition, prioritizing certification readiness and supplier dialogue over reactive measures.

Source

National Medical Products Administration (NMPA) official announcement. Pending clarification: Whether non-invasive RF devices (e.g., home-use beauty tools) face lower-tier classification.

Related Intelligence